FDA Adverse Event Injury Summary report: N

GRANUFLO

MDR report key: 4112615 · Received September 10, 2014

Report

Report Number
1225714-2014-11142
Event Type
Injury
Date Received
September 10, 2014
Date of Event
August 1, 2012
Report Date
January 29, 2013
Manufacturer
FRESENIUS MEDICAL CARE NORTH AMERICA
Product Code
KPO
PMA / PMN Number
K030497
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

NO PRODUCT WAS RETURNED. THERE WAS NO INDICATION THAT A FMC DEVICE MALFUNCTIONED OR CAUSED A SERIOUS INJURY. THE INVESTIGATION OF THE FMC CONCENTRATE DEVICE, INCLUDING REVIEW OF THE DEVICE HISTORY RECORD, AND LABELING EVAL REVEALED NO DEVIATIONS OR NON-CONFORMANCES. THE REPORTED DEVICE RELATED EVENT IS UNCONFIRMED. A CLINICAL INVESTIGATION INDICATES A CARE MANAGEMENT PROBLEM BETWEEN THE PT AND THE CARE TEAM. THE FMC PHARMACOVIGILANCE PHYSICIAN CONCLUDES THE ALLEGATIONS ARE NOT CONSISTENT WITH THE OCCURRENCE OF A SERIOUS INJURY; FROM THE NARRATIVE OF THE CUSTOMER, IT APPEARS AS IF THE PT HAS PROBLEMS MANAGING INTERDIALYTIC FLUID INTAKE. THERE IS NO HISTORY OF DEVICE MALFUNCTION, HYPOKALEMIA, METABOLIC ALKALOSIS, OR SERIOUS INJURY. THIS IS A RETROSPECTIVE MDR BEING SUBMITTED BY FRESENIUS MEDICAL CARE AS A REMEDIATION ACTION COMMITTED TO FDA REGARDING ALL POTENTIAL ADVERSE EVENTS RECEIVED BETWEEN 03/21/2011 TO 03/11/2013.

Description of Event or Problem · 1

IT WAS REPORTED BY A PT FAMILY MEMBER, THE PT (RELATIVE OF THE REPORTER) WAS RETURNED FROM THE DIALYSIS TREATMENT CTR WITHOUT HAVING RECEIVED DIALYSIS TREATMENT. HE WAS TAKEN TO THE HOSP FOR TREATMENT. THE HOSP DID NOT PROVIDE DIALYSIS TREATMENT. THE REPORTER ALLEGES THE CARE AT THE DIALYSIS TREATMENT CTR IS IMPROPER/INSUFFICIENT. THE REPORTER STATED THE PT, "...WAS GIVEN GRANUFLO, WHICH CAUSES HEART ATTACKS AND STROKES."

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
559528 GRANUFLO DRY ACID CONCENTRATE FOR BICARBONATE DIALYSIS KPO FRESENIUS MEDICAL CARE NORTH AMERICA NA

Patients

Seq Age Sex Outcome Treatment
1 Other